Omada Health, Inc. (NASDAQ:OMDA) Stock Has Consensus Target Price of $26.67 According to Analysts

Omada Health, Inc. (NASDAQ:OMDA) has earned an average recommendation of “Moderate Buy” from the fourteen research firms that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and eleven have given a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $26.67.

Several research firms have recently weighed in on OMDA. BMO Capital Markets reissued an “outperform” rating and set a $24.00 price objective on shares of Omada Health in a research note on Friday, August 7th. Wall Street Zen upgraded Omada Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Needham & Company LLC restated a “buy” rating and set a $28.00 price objective on shares of Omada Health in a report on Friday, September 11th. Barclays raised their target price on shares of Omada Health from $25.00 to $27.00 and gave the stock an “overweight” rating in a report on Friday, September 11th. Finally, Canaccord Genuity Group boosted their price target on shares of Omada Health from $24.00 to $28.00 and gave the company a “buy” rating in a report on Tuesday, July 21st.

Insiders Place Their Bets

In other news, CAO Craig Gracey sold 1,042 shares of the firm’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $25.00, for a total value of $26,050.00. Following the completion of the sale, the chief accounting officer owned 15,441 shares of the company’s stock, valued at $386,025. This trade represents a 6.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, President Wei-Li Shao sold 4,036 shares of Omada Health stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $21.85, for a total value of $88,186.60. Following the transaction, the president owned 295,313 shares in the company, valued at $6,452,589.05. This represents a 1.35% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 193,245 shares of company stock worth $4,411,838 over the last three months. Company insiders own 6.38% of the company’s stock.

Institutional Trading of Omada Health

A number of hedge funds have recently made changes to their positions in OMDA. BlackRock Inc. acquired a new stake in shares of Omada Health during the second quarter worth approximately $48,775,000. Jefferies Financial Group Inc. purchased a new stake in Omada Health in the 2nd quarter worth approximately $15,016,000. BIT Capital GmbH boosted its stake in shares of Omada Health by 52.4% during the 4th quarter. BIT Capital GmbH now owns 940,238 shares of the company’s stock valued at $14,837,000 after buying an additional 323,365 shares during the period. Madryn Asset Management LP acquired a new stake in shares of Omada Health during the 2nd quarter valued at $12,814,410. Finally, Walleye Capital LLC purchased a new position in shares of Omada Health during the 2nd quarter valued at $11,648,000.

Omada Health Price Performance

Shares of OMDA opened at $19.72 on Friday. The firm’s 50 day moving average is $22.08 and its 200-day moving average is $18.44. Omada Health has a 12-month low of $10.28 and a 12-month high of $26.92. The stock has a market capitalization of $1.21 billion, a P/E ratio of 394.40 and a beta of 1.86.

Omada Health (NASDAQ:OMDA) last issued its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.10. The firm had revenue of $87.83 million during the quarter, compared to analysts’ expectations of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. As a group, equities research analysts forecast that Omada Health will post 0.09 EPS for the current fiscal year.

Omada Health Company Profile

Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.

The company’s offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada’s programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.

Omada primarily serves members through employers, health plans and healthcare organizations in the United States.